Financial Growth of Square Pharma

In: Other Topics

Submitted By teeloqq
Words 4202
Pages 17


April 20, 2008



April 20, 2008

Members of the Group

A single individual can achieve no noble objective. We are indebted to a number of persons for their kind advice, suggestions, directions, & co-operations which have enable us to prepare this report. First of all I would like to thank Utpual for his contribution into this report. We would like to thank Kazal Pharmacy for their suggestion and ideas.

Riaheen Farzana
Senior Lecturer
ULAB School of Business
University of Liberal Arts Bangladesh
Dhanmondi, Road- 4/A Satmosjid Road,

Subject: Submission of the Report.

Dear Madam,
Here is the Report on Performance of Square Pharmaceuticals Ltd based on the year 2006-2007 Which we the group members studied. We have tried our best to prepare the report in consistence with the optimal standard under your valuable direction.

We would be very grateful if you accept our report modestly as it may suffer from some shortcomings. We desired…...

Similar Documents

Square Pharma

...A. Historical Background: Square is one of the well-known companies in Bangladesh. At present it has a huge number of products and it has employees more than 12000.Square pharmaceutical is a sister company of square group of industries. Mr. Samson H Chowdhury is the founder of this company. In 1952, he started a small pharmacy in Ataikula village, which is about 160 km off capital Dhaka in the northwest part of Bangladesh. Then he ventured into a partnership pharmaceutical company with three of his friends in 1958. They named the company “SQUARE”. They choose this name because four friends started this company and it signifies accuracy and perfection meaning quality. From then square started its journey and become a renowned organization. Eventually this small company of 1958 turned into a publicly listed diversified group of companies and employing more than 12,000 people. The current yearly group turnover is 300 million USD. And now Square Pharmaceuticals Limited is the largest pharmaceutical company in Bangladesh and it has been continuously in the 1st position among all national and multinational companies since 1985. It was established in 1958 and converted into a public limited company in 1991The sales turnover of SPL was more than Taka 7.5 Billion (US$ 107.91 million) with about 16.92% market share (April 2006– March 2007) having a growth rate of about 23.17%. B. Background of the Export: ➢ When, Why & How Square Pharmaceuticals stared its export......

Words: 971 - Pages: 4

Financial Report of Square

...Economics Daffodil International University Submitted By: Rakib Uddin ID No: 103-11-1716 Section: C B.B.A (27th Batch) Date of Submission: 3rd June, 2012 Department of Business Administration Daffodil International University BUDGET FY 2012-2013 According to the latest forecast, the growth of global economy may stand at 3.5 percent in 2012. The developing and emerging economies might grow at 5.7 percent. In FY 2010-11, we achieved a growth rate of 6.7 percent and as per the provisional estimates of BBS, in FY2011-12 the growth will be 6.3 percent. GDP growth will stand in the neighborhood of 7 percent. We have set our growth target at 7.2 percent for FY2012-13. In the last three years, we had an export growth of 21.2 percent. In the current fiscal year, up to April 2012, the export growth is 8.4 percent. Besides export, our import increased by 22.2 percent on an average in the last three years. In the current fiscal year, up to April 2012, import grew by 8.7 percent. During this period, import of capital machinery increased by 20.7 percent and that of industrial raw materials increased by 19.8 percent. We are pursuing a restrained monetary policy to manage aggregate demand. Up to March 2012, the growth of money supply, on year on yearbasis, stood at 17.6 percent. Private sector credit flow grew by 19.4percent. In the first half of the current fiscal year, we observed that foreign currency reserve is depleting and the exchange rate of Taka going down. This yielded result......

Words: 970 - Pages: 4

Strategy Square Pharma

...Bargaining power of suppliers 10 2.5 Bargaining power of buyers 11 CHAPTER 03: COMPANY ANALYSIS 13 3.1 SWOT ANALYSIS 13 3.1.1 STRENGTHS: 13 3.1.2 WEAKNESSES: 14 3.1.3 OPPORTUNITIES: 14 3.1.4 THREATS: 15 3.2 Competitive Strategy Analysis: 16 3.2.1 Advantage of SPL in using an Integrated Strategy: 17 3.2.2 Disadvantages of SPL in using an Integrated Strategy: 17 CHAPTER 01: COMPANY OVERVIEW 1.1 Introduction The flagship company of the Square group of industries, Square Pharmaceuticals Limited (SPL) is the largest pharmaceuticals company in Bangladesh. Founded in 1958 and headquartered in Dhaka, Bangladesh, SPL develops, manufactures and markets drugs for humans and the animal world. The company owns and operates modern pharmaceutical factories mainly in Bangladesh and also has a separate division to operate a modern chemical factory which produces and sells basic chemical products. It also has divisions to produce and sell agrovet and pesticide products. It exports its products to Europe, Asia, Africa and South America. SQUARE Pharmaceuticals Limited (SPL) is the largest pharmaceutical company in Bangladesh and is leading the Pharmaceuticals sector from the very beginning. It has been continuously in the 1st position among all national and multinational companies since 1985. SPL offers a range of pharmaceutical products, which include alimentary preparations, anesthetics, antiallergy preparations, antidiabetic preparations, antihaemorrhagic, antiparasite......

Words: 3682 - Pages: 15

Financial Analysis of Square Pharma

...Institute of Business Administration (IBA) MBA Admission Test 50th Batch ( Session 2012 – 2013 ) MBA Admission Test (2012 – 13) of the Institute of Business Administration (IBA), University of Dhaka will be held on Friday, June 14, 2013 at 10 am. For all other certificates, equivalence will be determined by the Equivalence Committee of IBA. ELIGIBILITY All applicants must have at least a Bachelor Degree in any field of study. The minimum qualifying point is seven (07) for all applicants. The points are calculated as follows: SELECTION PROCEDURE The test has two components: Written Assessment and Interview. The written assessment component evaluates applicants’ aptitude in Language, Mathematics, and Analytical ability. An applicant must obtain a minimum qualifying score in each of the above areas to pass of the written test and appear for the interview. All Bangladeshi applicants must take the admission test. An applicant with foreign nationality with minimum 70 percentile in GMAT may be exempted from the written assessment. However, they will be required to appear for an interview. SSC and HSC or Equivalents SSC GPA/Div >= 4.0/Ist >= 3.0/2nd >= 1.0/3rd HSC GPA/Div >= 4.0/Ist >= 3.0/2nd >= 1.0/3rd O-level GPA A-level GPA Points Earned 3 2 1 * * >= 3.0 >= 2.5 >= 1.0 >=2.5 >= 2.0 >= 1.0 Applicants who have taken O-Level examination must pass at least five (05) subjects (including mathematics) with a minimum of grade D in each of the subjects.......

Words: 458 - Pages: 2

Case Study on Square Pharma

...The Lawyers & Jurists Career Upload Works Monthly Journals Set Up Business Home About Us Our Lawyers Our Clients Services Career Online resources Contact Us Here you are: The Lawyers & Jurists > resources > Industries > Supply Chain Management SYSTEMS of SQUARE PHARMACEUTICALS LTD. Supply Chain Management SYSTEMS of SQUARE PHARMACEUTICALS LTD. view with images and charts Supply Chain Management SYSTEMS of SQUARE PHARMACEUTICALS LTD. Introduction: Formally designed Commercial Department has been renamed as “Supply Chain Management” (SCM) in Mid July 2007. When only one Manager was guiding as Head of the Department but there was no gap for monitoring the officers’ activities. SCM started its journey with wider functions as a result it would divide into two folds – Local Purchase International Trade Manager for the new section take responsibility to supervise activities more effectively and efficiently. Number of potential individuals have joined in SCM who are doing there jobs with total satisfaction. DGM is guiding works of both the sections and Executive Director (Admin) is monitoring & advising overall activities monitoring. SCM has recently generated new SOP considering present work volume and business environment. And DGM is getting to the point all out support and cooperation of Manager – International Trade and Manager – Local Purchase. Presently about 42 people are working in......

Words: 8546 - Pages: 35

Financial Statement Analysis of Square Pharmaceuticals Ltd.

...|FINANCIAL STATEMENT ANALYSIS | Analyzing financial statements involves evaluating three characteristics: a company’s liquidity, profitability and solvency. A short-term creditor such as a bank is primarily interested in liquidity – the borrower to pay obligations when they come due. A long-term creditor, such as a bondholder, looks to profitability and solvency measures that indicate the company’s ability to survive over a long period of time. Similarly, stockholders look at the profitability and solvency of the company and want to assess the likelihood of dividends and the growth potential of the stock. Three commonly used tools for financial statement analysis are: i. Horizontal analysis evaluates a series of financial statement data over a period of time. ii. Vertical analysis evaluates financial statement data by expressing such item in a financial statement as a percentage of a base amount. iii. Ratio analysis expresses the relationship among selected items of financial statement data. BRIEF HISTORY OF SQUARE PHARMACEUTICALS LTD. Square Pharmaceuticals Ltd. is a renowned company in Bangladesh. It is a flagship company in the pharmaceutical industry which has reached this mountain of success by fighting many potential competitors like BEXIMCO Pharma, INCEPTA, ACME, RENETA, OPSONIN, SK+F, SANOFI-AVENTIS etc. It initially started as a Partnership in 1958. It......

Words: 3064 - Pages: 13

Financial Analysis of Wyeth Pharma

...FINANCIAL ANALYSIS OF WYETH PAKISTAN LIMITED By: OZAIR ARSHAD INDEX 1. Introduction 2. History and Profile 3. Key Activities of Wyeth 4. Wyeth Products Profile 5. Data Collection & Market Assessment 6. Main Competitors 7. Share Price in Last 12 Months 8. Shareholding Pattern 9. The Director’s Report 10.The Auditor’s Report 11.Financial Ratios & Analysis 12. Horizontal Analysis a) Income Statement b)Balance Sheet 13. Vertical Analysis a)Balance Sheet b) Income Statement 14. Financial Analysis & Conclusions i) Gross Profit Margin ii) Net Profit Margin iii) Return on Assets iv) DPS & EPS 15. Annexure 16. References 1. Introduction Wyeth, formerly one of the companies owned by American Home Products Corporation (AHP), is a pharmaceutical company The company was based in Madison, New Jersey, USA. They were known for manufacturing the over-the-counter (OTC) drugs Robitussin and the analgesic Advil (ibuprofen), as well as the prescription drugs Premarin and Effexor, which both boast over US$3 billion in sales annually. Wyeth has multiple subsidiaries in different countries of the world its Pakistan branch is known as Wyeth Pakistan Limited. This is a public limited company incorporated in 1949 in Pakistan. The company is listed on the Karachi and Lahore Stock exchange. The company is engaged in manufacturing and marketing of research based ethical specialties and other pharmaceutical products. 2. History & Profile Late 18th Century In 1860, pharmacists John......

Words: 4036 - Pages: 17

Financial Analysis of Square Pharma

...Question 1# Principal activities of SQUARE Pharmaceuticals: * Square strives for top quality health care products at the least cost reaching the lowest rungs of the economic class of people in the country. We value our social obligations. * Square owe their shareholders and strive for protection of their capital as well as ensure highest return and growth of their assets. * Square works for best compensation to all the employees who constitute the back-bone of the management and operational strength of the company through a pay-package composing salary/wages, allowances, bonuses, profit participation, leave salary and superannuation & retirement benefits. * Square works for the best co-operation of the creditors & debtors the banks & financial Institutions who provide financial support when we need them, the suppliers of raw materials &suppliers who offer them at the best prices at the opportune moments, the providers of utilities- power, gas & water etc. and the customers who buy our products & services by redeeming their claim in time by making prompt payment and by distributing proper product on due dates to our customers. * Square strives for fulfillment of our responsibility to the government through payment of entire range of due taxes, duties and claims by various public agencies like municipalities etc. * Square works as responsible citizen, for a social order devoid of malpractices, anti-environmental behaviors,......

Words: 4003 - Pages: 17

Financial Ratio Analysis of Square Pharmaceuticals Limited

...Electronic copy available at: Financial Ratio Analysis of Square Pharmaceuticals Limited Asif Ahmed ACA Trainee Accountants KPMG in Bangladesh Rahman Rahman Huq Chartered Accountants 9 Mohakhali C/A Dhaka – 1212. ACA Student The Institute of Chartered Accountants (ICAB) CA Bhaban, Kazi Nazrul Islam Avenue Dhaka, Bangladesh Contact E-mail: Electronic copy available at: Financial Ratio Analysis of Square Pharmaceuticals Limited 2 of 24 TABLE OF CONTENTS Page No. Executive Summary 3 Chapter 1 Introduction 4 - 6 1. Introduction 4 2. Objectives of Study 4 3. Scope of Study 5 4. Methodology of Analysis 5 5. Limitations or Problem Statement 6 Chapter 2 Key Financial Highlights 7 - 11 2.1. Overview of the Organization 7 2.2. Key Financial Highlights 7 Chapter 3 Ratio Analysis 12 - 19 3.1. Liquidity Ratio Analysis; 12 3.2. Asset Management Ratio Analysis; 13 3.3. Debt Management Ratio Analysis; 15 3.4. Profitability Ratio Analysis; and 16 3.5. Market Value Ratio Analysis. 17 Conclusion 20 Recommendations 21 Bibliography 22 Annexure 23 Financial Ratio Analysis of Square Pharmaceuticals Limited 3 of 24 EXECUTIVE SUMMARY This paper is mainly an analytical outcome of financial ratio analysis of Square Pharmaceuticals Limited and pharmaceuticals industry. Eleven (11) ratios are selected to judged the various aspects of efficiency of the company, including......

Words: 4143 - Pages: 17

Financial Statement Analysis of Square Pharma

...INTRODUCTION: Objectives of the Report: 1. To know the current financial performance of the two companies. 2. To know the future prospect of the companies. 3. To compare the financial position of the two companies. Scope of the report: 1. Studying the pros and cons of the financial statements of a company, it is possible to predict the probable future growth of a company Methodology: Data were collected from Annual Reports of Square Pharmaceuticals Ltd. and Renata Pharmaceuticals Ltd. from the year 2003 to 2008. Three types of financial tools were used to analyze the data which are: 1. Horizontal Analysis 2. Vertical Analysis and 3. Ratio Analysis. LITERATURE REVIEW: Financial Analysis: The art of transforming data from financial statements into information that is useful for informed decision making is financial analysis. Financial analysis involves the use of various financial statements. These statements do several things.  First the balance sheet summarizes the assets, liabilities and owners’ equity of a business at a moment in time usually the end of a year or a quarter. Next the income statement summarizes the revenue and expenses of the firm over a particular period of time, again usually a year or a quarter. Need for Comparative Analysis: Every item reported in a financial statement has significance. We know a company had a certain amount of cash on the balance sheet but we do not know whether the amount represents an increase over prior......

Words: 1445 - Pages: 6

Square Pharma

...of any company. We have chosen Square Pharmaceutical Ltd and the job post on which we have prepared our report is Medical Promotion Officer. We visited Square Pharmaceuticals Limited. There we appointed with Mr. Younus Ali (Sr. Manager, HRD) and Mr. Tamim Ahsan( Territory officer in Dhaka region). They were very cordial and helpful to us share their experience and provide the required information as they can provide within the policy. We asked them different relevant questions and information to provide. 1.1. Profile of Square Pharmaceuticals Ltd. Corporate Headquarters | : SQUARE CENTRE 48, Mohakhali Commercial Area Dhaka 1212, Bangladesh | Factory | : Shalgaria, PabnaTown, Pabna | Established | :1958 | Constitution | : Public Ltd Company | Founder Chairman | : Mr. Samson H Chowdhury | Chairman | : Mr. Samuel S Chowdhury | Managing Director | : Mr. Tapan Chowdhury | Details of Business | : 1. Pharmaceuticals Products 2. Bulk Chemicals 3. AgroVet Products | Manufacturing Units | :1. Pharmaceuticals Division 2. Agro Vet Division 3. Chemical Division | 1.2. Human Resource Department of Square Pharmaceutical Ltd SQUARE, with its progressive business outlook, believes and practices corporate work culture with a classic blend of efficiency and equity. SQUARE believes in company growth by increasing efficiency level of employees and for that offering excellent environment and support for skill and knowledge up gradation. SQUARE values productivity as the......

Words: 2745 - Pages: 11

Financial Ratio Analysis of Square Pharma & Beximco Pharma

...|Financial Ratio Analysis | | | |Performing Year: 2008 & 2009 | | | | Beximco Pharmaceuticals ltd. & Square Pharmaceuticals ltd. Submitted by Group Name: Peace Messengers • Islam Mohammad Samiul (09-14649-3) • Hamid Faisal (09- 15037 -3) Course Name: Financial Management Section: H AIUB Letter of Transmittal 01/03/2011 Mrs. Farzana Islam Honorable Faculty A.I.U.B. Dear Madam, It gives us immense pleasure to submit a report on “Financial Ratio Analysis”. This report is submitted as a partial fulfillment/ as a part of our course “Financial Management ”. We have choose two renowned pharmaceuticals companies of the country who are “Beximco Pharmaceuticals Ltd.” and “Square Pharmaceuticals Ltd.”The preparation of the report has given us in-depth knowledge on “Financial Ratio Analysis”. We have given our best effort to make it a worthy one and each aspect of the problem is considered and studied as required. If any confusion arises or further explanation is needed, we shall be available to explain the matter to you as and when required despite having limitations. Your compassionate and......

Words: 2113 - Pages: 9

Square Pharma

...booming, with rising salaries in the services sector in general and the IT sector in particular. Even government employees got pay hikes, thanks to the pay revisions periodically instituted for all the government employees. The employees in the private and public sectors were more affluent than in 2003, thus were even able to look for options beyond Nano. Prompted by increasing competition within the banking sector in India, more banks were vying to lend car financing to customers for the first time, creating a rosy prospect for Tata Motors and its new car, the Nano. It appeared that the stage was set for the overwhelming acceptance of Nano. Moreover, with the acquisition of Jaguar and Land Rover, Tata Motors had the technical and financial muscle of being the top automaker in India. The credibility Tata Group enjoys as one of the most respected business houses in the world added authenticity to the claim, and buzz to the idea, that they could in fact deliver the car of the people and for the people. Tata Motors placed big hopes on India’s small towns. In addition, the company saw potential from a significant number of senior citizens and existing car owners who might opt for a second or third car for short rides. It was predicted that rising rural incomes would push more rural people to move from two-wheelers to cars, with the low-priced Tata Nano being the first affordable option. “I hope it will be seen as the car…which changes the manner in which people in......

Words: 5320 - Pages: 22

Financial Development and Economic Growth

...Literature review 1 1.2. Theoretical review of financial development and economic growth nexus 1 1.3 Review of the empirical literature 4 1.3.1 Time series 5 1.3.2 Cross-country studies 6 1.3.3 Panel data studies 7 3 Conclusions 8 4 References 9 1 Introduction “Finance is powerful. The financial system can be an engine of economic prosperity – or a destructive cause of economic decline and misery.” Levine, R. (2011) p.85 Obviously, financial system and economy are related. But what is the nature of this relationship? The objective of this paper is to critically evaluate the existing theoretical and empirical literature on the finance-growth nexus. What is the role of the financial sector in economic growth? Does finance cause growth or simply follows it? There is no wide agreement about this task among recognised economists. Even Nobel Prize winners disagree in regard to the role of finance in economic development. Levine (2003) states that the role of finance as a major determinant of economic growth is over-stressed. Moreover Levine (2003) argued that where enterprise leads finance follows. Quite the opposite, important acknowledgment should be taken into account and it follows as “[the idea] that financial markets contribute to economic growth is a proposition too obvious for serious discussion.” Levine (2003) p.1 Similar to that, he also declared that the finance growth nexus cannot be safely ignored without......

Words: 3466 - Pages: 14

Square Pharma Business Report

...[pic] [pic] [pic] EXECUTIVE SUMMARY Square Pharmaceutical Limited Bangladesh is one of the leading pharmaceuticals in Bangladesh. SQUARE today symbolizes a name – a state of mind. But its journey to the growth and prosperity has been no bed of roses. From the inception in 1958, it has today burgeoned into one of the top line conglomerates in Bangladesh. Square Pharmaceuticals Ltd., the flagship company, is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1985 and is now on its way to becoming a high performance global player. Their Future Focus are- • Strengthen its position in the present markets. • Work is in progress to enter into regulated markets in Europe and United States. In this report, we have tried to show you the actual business environment of Square Pharmaceutical Limited Bangladesh. In details we have included company’s basic profile, its annual business report and the background of the organization. CONTENT • Company Profile 5 • Square Pharmaceuticals Ltd. 6-23 • Management 7 • Square Quality Policy 9 • Financial Report 10-17 • Their Products ...

Words: 2256 - Pages: 10